Persistent URL of this record https://hdl.handle.net/1887/103523
In Collections
This item can be found in the following collections:
LONG-TERM SAFETY AND EFFICACY OF CERTOLIZUMAB PEGOL IN PATIENTS WITH PSORIATIC ARTHRITIS WITH AND WITHOUT PRIOR ANTI-TUMOR NECROSIS FACTOR EXPOSURE: 96-WEEK OUTCOMES OF THE RAPID-PSA TRIAL
- All authors
- Mease, P.J.; Fleischmann, R.; Wollenhaupt, J.; Deodhar, A.; Gladman, D.; Arledge, T.; Peterson, L.; Heijde, D. van der
- Date
- 2014-10-31
- Volume
- 32
- Issue
- 5
- Pages
- 786 - 786